Symbol
|
PMWLTQ | HZAEFG | Z09KMZ | ACKUTQ | ACLATQ | ACRFTQ |
---|---|---|---|---|---|---|
Name | Multi Reverse Convertible | Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible |
Basiswert
|
Amgen Inc. / Lonza Group N / Novartis Sandoz Basket / Pfizer Inc. / Roche AG | Amgen Inc. / Gilead Sciences Inc. / Vertex Pharmaceuticals Inc. | Amgen Inc. / Nike Inc. / Occidental Petroleum Corp. | Amgen Inc. / Intuitive Surgical Inc. / Novo Nordisk AS (B) | Amgen Inc. / Intuitive Surgical Inc. / Novo Nordisk AS (B) | Amgen Inc. / Intuitive Surgical Inc. / Novo Nordisk AS (B) |
Emittent
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Fälligkeit
|
09.02.2026 | 29.04.2026 | 22.05.2025 | 17.03.2027 | 17.03.2027 | 14.04.2027 |
Ratio | - | - | - | - | - | - |
Ausübungs-Preis
|
56.45 | 53.408 | 249.128 | 227.402 | 229.152 | 202.783 |
Maximal- rendite p.a. |
- | 10.21% | n/a | 14.18% | 10.62% | 10.25% |
Geld | 83.69 | 99.40 | - | 91.20 | 94.88 | 101.07 |
Brief | - | 100.20 | - | 92.20 | 95.88 | 102.07 |